Peptide Receptor Radionuclide Therapy Using 177Lu-DOTATATE: Nursing Roles in Managing Patients With Gastroenteropancreatic Neuroendocrine Tumors

Bonita Bennett,Linda Gardner,Pamela Ryan
DOI: https://doi.org/10.1188/24.cjon.79-87
IF: 1.283
2024-02-16
Clinical Journal of Oncology Nursing
Abstract:BACKGROUND: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a diverse family of cancers that occur within the gastrointestinal tract and pancreas. Peptide receptor radionuclide therapy (PRRT) via 177Lu-DOTATATE is a newer therapeutic option for certain patients with somatostatin receptor-positive GEP-NETs.
nursing,oncology
What problem does this paper attempt to address?